Interpace Biosciences, Inc. (IDXG)
OTCMKTS: IDXG · Delayed Price · USD
1.360
-0.060 (-4.23%)
May 1, 2024, 12:54 PM EDT - Market closed
Interpace Biosciences Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Year | Current | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 - 1997 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Market Capitalization | 6 | 5 | 4 | 31 | 13 | 19 | 23 | 16 | 8 | 7 | 27 | Upgrade
|
| Market Cap Growth | - | 5.78% | -85.73% | 144.16% | -32.46% | -16.86% | 40.46% | 100.73% | 11.04% | -73.02% | -96.23% | Upgrade
|
| Enterprise Value | 14 | 12 | 16 | 41 | 15 | 24 | 16 | 1 | 15 | 7 | 31 | Upgrade
|
| PE Ratio | 7.47 | 5.81 | -0.75 | -2.09 | -0.48 | -0.70 | -1.85 | -1.31 | -0.96 | -0.63 | -1.66 | Upgrade
|
| PS Ratio | 0.15 | 0.12 | 0.14 | 0.75 | 0.39 | 0.78 | 1.03 | 1.01 | 0.61 | 0.76 | 0.22 | Upgrade
|
| PB Ratio | -0.31 | -0.31 | -0.07 | -0.73 | -0.43 | 1.44 | 0.68 | 0.40 | 1.22 | 0.55 | 1.33 | Upgrade
|
| P/FCF Ratio | 1.79 | 1.40 | -0.55 | -3.40 | -0.78 | -0.98 | -2.47 | -1.05 | -0.89 | -0.36 | -0.96 | Upgrade
|
| P/OCF Ratio | 1.57 | 1.23 | -0.57 | -3.54 | -0.87 | -0.99 | -2.60 | -1.05 | -0.89 | -0.36 | -1.63 | Upgrade
|
| EV/Sales Ratio | 0.34 | 0.31 | 0.49 | 1.00 | 0.45 | 0.98 | 0.75 | 0.05 | 1.17 | 0.77 | 0.26 | Upgrade
|
| EV/EBITDA Ratio | 3.73 | 3.22 | -4.14 | -5.05 | -0.68 | -1.17 | -2.32 | -0.08 | -1.37 | -0.28 | -3.39 | Upgrade
|
| EV/EBIT Ratio | 5.14 | 4.40 | -2.47 | -3.05 | -0.54 | -0.97 | -1.56 | -0.06 | -0.98 | -0.24 | -2.68 | Upgrade
|
| EV/FCF Ratio | 4.11 | 3.72 | -1.96 | -4.55 | -0.91 | -1.23 | -1.80 | -0.05 | -1.71 | -0.36 | -1.11 | Upgrade
|
| Debt / Equity Ratio | -0.64 | -0.64 | -0.26 | -0.32 | -0.16 | 0.54 | 0 | 0 | 1.21 | 0.64 | 2.33 | Upgrade
|
| Debt / EBITDA Ratio | 3.06 | 2.92 | -4.26 | -1.68 | -0.22 | -0.35 | - | - | -0.71 | -0.32 | -3.00 | Upgrade
|
| Debt / FCF Ratio | 3.37 | 3.37 | -2.01 | -1.51 | -0.29 | -0.37 | - | - | -0.88 | -0.42 | -0.98 | Upgrade
|
| Quick Ratio | 0.49 | 0.49 | 0.69 | 0.60 | 0.59 | 0.72 | 1.83 | 2.33 | 0.19 | 0.52 | 1.12 | Upgrade
|
| Current Ratio | 0.59 | 0.59 | 0.85 | 0.78 | 0.77 | 0.95 | 2.09 | 2.48 | 0.26 | 0.82 | 1.34 | Upgrade
|
| Asset Turnover | 2.74 | 3.09 | 1.99 | 1.08 | 0.71 | 0.35 | 0.45 | 0.30 | 0.31 | 0.14 | 1.03 | Upgrade
|
| Interest Coverage | 5.64 | 2.79 | -3.81 | -12.76 | -48.37 | -54.39 | -36.61 | -14.53 | -3.00 | -10.91 | -22.38 | Upgrade
|
| Return on Equity (ROE) | -5.30% | -5.30% | 9.30% | 34.76% | 90.09% | -204.51% | -37.01% | -30.56% | -127.58% | -87.10% | -79.88% | Upgrade
|
| Return on Assets (ROA) | 6.16% | 6.16% | -36.70% | -38.37% | -57.36% | -38.58% | -25.16% | -22.79% | -19.94% | -16.77% | -13.87% | Upgrade
|
| Return on Capital (ROIC) | -70.11% | -70.20% | 8.17% | 40.89% | 109.10% | -118.94% | -36.79% | -15.74% | -44.62% | -188.51% | -28.49% | Upgrade
|
| Earnings Yield | 13.47% | 17.20% | -133.07% | -47.74% | -207.11% | -142.23% | -54.11% | -76.16% | -104.28% | -157.81% | -60.26% | Upgrade
|
| FCF Yield | 55.76% | 71.19% | -181.83% | -29.37% | -127.69% | -101.91% | -40.49% | -95.34% | -111.88% | -280.65% | -103.96% | Upgrade
|
| Buyback Yield / Dilution | -1.62% | -2.97% | -2.49% | -2.63% | -7.55% | -33.03% | -78.61% | -768.17% | -17.31% | -3.89% | 89.88% | Upgrade
|
| Total Shareholder Return | -1.62% | -2.97% | -2.49% | -2.63% | -7.55% | -33.03% | -78.61% | -768.17% | -17.31% | -3.89% | 89.88% | Upgrade
|
Sources: The data provider is Financial Modeling Prep and the numbers are sourced from SEC filings.